We are live on
!
Find out more
VCM
Versant Capital Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
34.21%
This Fund
S&P 500
This Quarter
Est. Return
+2.67%
1 Year Est. Return
+34.21%
3 Year Est. Return
+82.39%
5 Year Est. Return
+89.4%
10 Year Est. Return
+245.66%
AUM
$1.01B
AUM Growth
+$217M
(+27%)
Cap. Flow
+$212M
Cap. Flow
% of AUM
20.87%
Top 10 Holdings %
Top 10 Hldgs %
33.44%
Holding
2,859
New
220
Increased
1,610
Reduced
469
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$57.7M |
| 2 |
Broadcom
AVGO
|
+$13.4M |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$10.3M |
| 4 |
iShares Russell Mid-Cap ETF
IWR
|
+$9.41M |
| 5 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$8.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$1.27M |
| 2 |
Avantis International Equity ETF
AVDE
|
+$1.24M |
| 3 |
AstraZeneca
AZN
|
+$1.1M |
| 4 |
GREK
Global X MSCI Greece ETF
GREK
|
+$1.07M |
| 5 |
HIMU
iShares High Yield Muni Active ETF
HIMU
|
+$779K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.87% |
| 2 | Financials | 6.8% |
| 3 | Industrials | 6.1% |
| 4 | Consumer Discretionary | 4.96% |
| 5 | Healthcare | 4.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Greif
GEF
$5.04B
| $31.9K | ﹤0.01% |
475
+178
| +60% | +$12.6K |
|
1527
UGI
UGI
$7.33B
| $31.7K | ﹤0.01% |
871
+335
| +63% | +$12.6K |
|
1528
Saic
SAIC
$5.35B
| $31.7K | ﹤0.01% |
334
+156
| +88% | +$15.3K |
|
|
LINE
1529
Lineage Inc
LINE
$9.65B
| $31.7K | ﹤0.01% |
967
+710
| +276% | +$26.3K |
|
1530
Pentair
PNR
$11B
| $31.6K | ﹤0.01% |
363
-1,469
| -80% | -$144K |
|
1531
ICF International
ICFI
$1.72B
| $31.6K | ﹤0.01% |
484
+73
| +18% | +$5.93K |
|
1532
LPL Financial
LPLA
$28.6B
| $31.6K | ﹤0.01% |
105
-42
| -29% | -$14.1K |
|
1533
FB Financial Corp
FBK
$3.04B
| $31.6K | ﹤0.01% |
608
| – | – |
|
1534
Texas Roadhouse
TXRH
$13.7B
| $31.5K | ﹤0.01% |
191
+10
| +6% | +$1.79K |
|
1535
Mercury Systems
MRCY
$6.52B
| $31.5K | ﹤0.01% |
432
| – | – |
|
1536
Fox Class B
FOX
$23.9B
| $31.5K | ﹤0.01% |
593
-1,495
| -72% | -$86.3K |
|
1537
Greenlight Captial
GLRE
$506M
| $31.5K | ﹤0.01% |
1,821
+93
| +5% | +$1.35K |
|
1538
Washington Trust Bancorp
WASH
$741M
| $31.5K | ﹤0.01% |
940
| – | – |
|
|
SEE
1539
DELISTED
Sealed Air
SEE
| $31.4K | ﹤0.01% |
746
| – | – |
|
1540
Tyra Biosciences
TYRA
$1.58B
| $31.4K | ﹤0.01% |
819
| – | – |
|
1541
Alpha and Omega Semiconductor
AOSL
$1.08B
| $31.4K | ﹤0.01% |
1,415
+453
| +47% | +$9.85K |
|
|
CAI
1542
Caris Life Sciences
CAI
$6.43B
| $31.3K | ﹤0.01% |
1,753
+1,607
| +1,101% | +$35.1K |
|
1543
Nelnet
NNI
$4.7B
| $31.2K | ﹤0.01% |
242
-4
| -2% | -$526 |
|
|
SEM
1544
DELISTED
Select Medical
SEM
| $31.2K | ﹤0.01% |
1,915
+31
| +2% | +$485 |
|
1545
Haemonetics
HAE
$4B
| $31.2K | ﹤0.01% |
553
+49
| +10% | +$3.19K |
|
1546
Target Hospitality
TH
$1.64B
| $31K | ﹤0.01% |
3,345
-22
| -0.7% | -$175 |
|
1547
CorVel
CRVL
$3.19B
| $31K | ﹤0.01% |
568
+305
| +116% | +$17.6K |
|
1548
LyondellBasell Industries
LYB
$19.2B
| $30.9K | ﹤0.01% |
383
+218
| +132% | +$12.9K |
|
1549
Microchip Technology
MCHP
$46B
| $30.8K | ﹤0.01% |
476
+134
| +39% | +$9.64K |
|
1550
Annaly Capital Management
NLY
$17.4B
| $30.8K | ﹤0.01% |
1,454
+549
| +61% | +$12.5K |
|
Similar funds
FLAM
AIM
MTCM
CNC
RIM
C
HH
EIA
Versant Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Versant Capital Management held 2,859 positions worth $1.01B, up 27% from $797M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Versant Capital Management deployed $212M of net new capital in Q1 2026, opening 220 new positions and adding to 1,610 existing holdings. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 14% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was VanEck Gold Miners ETF, an estimated $1.27M trimmed.
- Versant Capital Management's largest Q1 2026 buy was iShares Core MSCI Emerging Markets ETF: 120,588 shares worth $8.41M.
- Versant Capital Management added most to Microsoft in Q1 2026, an estimated $57.7M increase.
- Versant Capital Management's biggest Q1 2026 reduction was VanEck Gold Miners ETF, cutting an estimated $1.27M.
- Versant Capital Management fully exited AstraZeneca in Q1 2026, selling an estimated $1.1M.
- Versant Capital Management's ten largest holdings make up 33% of its $1.01B portfolio in Q1 2026.
- Versant Capital Management opened 220 new positions and closed 82 in Q1 2026.
- Versant Capital Management's portfolio value rose 27% quarter-over-quarter to $1.01B.
Based on Versant Capital Management's 13F filing for Q1 2026, filed 7 Apr 2026.